New TB Drugs Risk Becoming Ineffective If Misused, Lancet Report Warns
CIDRAP News: Report warns of rise in drug-resistant tuberculosis
“A new report warns that some of the incremental progress made in the global fight against tuberculosis (TB) could be lost with the emergence and spread of drug-resistant strains of the disease…” (Dall, 3/23).
Humanosphere: Emerging epidemic of multidrug-resistant TB ‘threatens decades of progress’
“…According to the report published in [The Lancet Respiratory Medicine] ahead of World TB Day (March 24), roughly one in five cases are now resistant to at least one major anti-TB drug. About five percent of all cases are considered ‘multidrug-resistant’ — to two vital first-line drugs, isoniazid and rifampicin — or ‘extensively drug-resistant’ — to fluoroquinolones and second-line injectable drugs as well…” (Lu, 3/23).
Inter Press Service: New Tuberculosis Drugs May Become Ineffective: Study
“…Multidrug-resistant tuberculosis reflects the meeting of an ancient and under-addressed disease — tuberculosis — with an emerging modern threat — antimicrobial resistance. The inappropriate use of antibiotics, including taking them without prescription or not following doctor’s orders closely is slowly rendering many antibiotics useless…” (Rowlands, 3/24).
VOA News: On World Tuberculosis Day, Doctors Warn Of New Drug-Resistant Bacteria
“…The report warns the new drugs must be prescribed as individually targeted treatments with clear dosing guidelines, to prevent further resistant TB strains from emerging…” (Ridgwell, 3/24).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.